Adrenal Myelolipoma: A Case Presentation
PDF
Cite
Share
Request
Case Report
P: 39-40
March 2018

Adrenal Myelolipoma: A Case Presentation

J Urol Surg 2018;5(1):39-40
1. Başkent University Faculty of Medicine, Department of Urology, Ankara, Turkiye
No information available.
No information available
Received Date: 25.01.2017
Accepted Date: 07.03.2017
Publish Date: 30.03.2018
PDF
Cite
Share
Request

ABSTRACT

Adrenal myelolipomas are non-functional benign tumors of hematopoietic and mature adipose tissue. Adrenal myelolipomas, which are generally detected in post-mortem examinations, have become more detectable thanks to evolution and frequent use of imaging techniques. This presentation elaborates on a case of 35-year old male patient presenting with no complaint but diagnosed with adrenal myelolipoma in histopathological examination following surrenalectomy operation for an adrenal mass incidentally detected on ultrasonography and computed tomography work-up.

Introduction

Adrenal myelolipoma is a rare type of benign tumors accounting for 2-4% of all adrenal tumors (1). Its histological structure contains mature adipose tissue and hematopoietic elements of myeloid and erythroid cells. Although it has quite a typical radiological presentation, misdiagnosis is frequent due to its rare manifestation. Since most of the cases are detected as asymptomatic incidental imaging findings, adrenal myelolipomas are also named as “insidentoma”. This condition was first defined in 1905 by Gierkel and was later named in 1929 by Oberling (2). It is a mostly unilateral, asymptomatic and hormonally inactive condition, and mostly seen in the age group of 40-60 years with a similar gender distribution. Most adrenal myelolipomas are smaller than 5 mm in diameter. Surgically removed cases are rare in the literature but detection rates are rising today with frequent use of imaging modalities including ultrasonography (USG), computed tomography (CT) and magnetic resonance imaging (3).

Case Presentation

A hyperechoic–slightly heterogeneous solid mass measuring 113x83 mm and showing minimal lobular contour was detected on the right adrenal gland in a 35-year-old male patient during USG done for right lumbar pain. Urine analysis, full blood count, prothrombin time and serum electrolytes were normal. CT taken for further investigation revealed a 103x110 mm heterogeneous lesion with smooth contours and limited fat density on the lateral side of the right suprarenal tissue (Figure 1). Hormonal analysis indicated inactivity. Open adrenalectomy was performed with a preliminary diagnosis of a mass in the supra renal gland. Macroscopic work-up of the surgical specimen revealed a 12x12 cm red-orange colored mass (Figure 2). Histopathological examination showed myelolipoma containing mature adipose tissues and hematopoietic elements. The patient was discharged on the 4th postoperative day.

Figure 1
Figure 2

Discussion

Adrenal myelolipomas are non-functional benign tumors of hematopoietic and mature adipose cells. Although they are generally unilateral in presentation and hormonally inactive, about 10% may be associated with endocrine diseases including Cushing’s syndrome, congenital adrenal hyperplasia, Conn’s syndrome, pheochromocytoma, and hyperthyroidism (4). There are many theories about their formation but the most accepted one is that they are formed as a result of metaplastic changes taking place in reticuloendothelial cells of blood vessels upon stimulations such as necrosis, infection and stress (5). The incidence of myelolipoma detected at autopsy is between 0.08% and 0.4% most myelolipomas reported in the literature are small tumors (0.5-5 cm) (3). About 10% of adrenal myelolipomas may grow and become symptomatic. The main complication of large myelolipomas is acute hemorrhage causing side or back pain. There was no other adrenal disease in this patient. The mass was 12 cm in diameter and it caused right lumbar pain. The generally accepted rule is to treat asymptomatic, hormonally inactive myelomas smaller than 6 cm conservatively, whereas to surgically remove symptomatic or complicating myelomas larger than 6 cm in diameter (6). Surgical treatment was preferred for this patient since the mass was very large and caused pain.